vs
Side-by-side financial comparison of Apyx Medical Corp (APYX) and Clearfield, Inc. (CLFD). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $19.2M, roughly 1.8× Apyx Medical Corp). Clearfield, Inc. runs the higher net margin — -1.8% vs -6.8%, a 5.0% gap on every dollar of revenue. On growth, Apyx Medical Corp posted the faster year-over-year revenue change (34.7% vs -3.2%). Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-2.8M). Over the past eight quarters, Apyx Medical Corp's revenue compounded faster (36.8% CAGR vs -3.5%).
Bovie Medical Corporation was an American medical device manufacturer of medical devices, electrosurgical products and energy technologies. It was based in Clearwater, Florida with a manufacturing facility in Bulgaria.
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
APYX vs CLFD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $19.2M | $34.3M |
| Net Profit | $-1.3M | $-614.0K |
| Gross Margin | 62.6% | 33.2% |
| Operating Margin | 0.1% | -5.3% |
| Net Margin | -6.8% | -1.8% |
| Revenue YoY | 34.7% | -3.2% |
| Net Profit YoY | 71.9% | 67.8% |
| EPS (diluted) | — | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.2M | $34.3M | ||
| Q3 25 | $12.9M | $23.4M | ||
| Q2 25 | $11.4M | $49.9M | ||
| Q1 25 | $9.4M | $47.2M | ||
| Q4 24 | $14.2M | $29.7M | ||
| Q3 24 | $11.5M | $5.6M | ||
| Q2 24 | $12.1M | $48.8M | ||
| Q1 24 | $10.2M | $36.9M |
| Q4 25 | $-1.3M | $-614.0K | ||
| Q3 25 | $-2.0M | $-9.1M | ||
| Q2 25 | $-3.8M | $1.6M | ||
| Q1 25 | $-4.2M | $1.3M | ||
| Q4 24 | $-4.6M | $-1.9M | ||
| Q3 24 | $-4.7M | — | ||
| Q2 24 | $-6.6M | $-447.0K | ||
| Q1 24 | $-7.6M | $-5.9M |
| Q4 25 | 62.6% | 33.2% | ||
| Q3 25 | 64.4% | 53.2% | ||
| Q2 25 | 62.3% | 30.5% | ||
| Q1 25 | 60.1% | 30.1% | ||
| Q4 24 | 63.0% | 29.2% | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 61.7% | 21.9% | ||
| Q1 24 | 58.1% | 7.7% |
| Q4 25 | 0.1% | -5.3% | ||
| Q3 25 | -6.5% | 10.3% | ||
| Q2 25 | -22.6% | 3.0% | ||
| Q1 25 | -32.4% | 0.6% | ||
| Q4 24 | -21.4% | -6.9% | ||
| Q3 24 | -31.6% | — | ||
| Q2 24 | -45.7% | -4.7% | ||
| Q1 24 | -64.6% | -26.4% |
| Q4 25 | -6.8% | -1.8% | ||
| Q3 25 | -15.4% | -38.8% | ||
| Q2 25 | -33.2% | 3.2% | ||
| Q1 25 | -44.0% | 2.8% | ||
| Q4 24 | -32.5% | -6.4% | ||
| Q3 24 | -40.9% | — | ||
| Q2 24 | -54.0% | -0.9% | ||
| Q1 24 | -74.0% | -16.0% |
| Q4 25 | — | $-0.04 | ||
| Q3 25 | — | $-0.65 | ||
| Q2 25 | — | $0.11 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | — | — | ||
| Q2 24 | $-0.19 | $-0.04 | ||
| Q1 24 | $-0.22 | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $96.4M |
| Total DebtLower is stronger | $37.5M | — |
| Stockholders' EquityBook value | $14.5M | $249.7M |
| Total Assets | $66.8M | $268.1M |
| Debt / EquityLower = less leverage | 2.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $96.4M | ||
| Q3 25 | $25.1M | $106.0M | ||
| Q2 25 | $29.3M | $117.2M | ||
| Q1 25 | $31.0M | $112.0M | ||
| Q4 24 | $31.7M | $113.0M | ||
| Q3 24 | $28.0M | $129.0M | ||
| Q2 24 | $32.7M | $123.8M | ||
| Q1 24 | $37.3M | $142.9M |
| Q4 25 | $37.5M | — | ||
| Q3 25 | $37.5M | — | ||
| Q2 25 | $37.5M | — | ||
| Q1 25 | $37.5M | — | ||
| Q4 24 | $37.5M | — | ||
| Q3 24 | $37.5M | $2.2M | ||
| Q2 24 | — | $2.1M | ||
| Q1 24 | — | — |
| Q4 25 | $14.5M | $249.7M | ||
| Q3 25 | $5.8M | $256.2M | ||
| Q2 25 | $7.3M | $264.5M | ||
| Q1 25 | $10.5M | $265.9M | ||
| Q4 24 | $14.2M | $267.4M | ||
| Q3 24 | $11.0M | $275.8M | ||
| Q2 24 | $14.7M | $274.6M | ||
| Q1 24 | $20.3M | $279.2M |
| Q4 25 | $66.8M | $268.1M | ||
| Q3 25 | $57.4M | $306.2M | ||
| Q2 25 | $58.2M | $314.7M | ||
| Q1 25 | $60.2M | $310.9M | ||
| Q4 24 | $64.8M | $303.2M | ||
| Q3 24 | $60.7M | $315.3M | ||
| Q2 24 | $65.4M | $318.1M | ||
| Q1 24 | $70.7M | $315.4M |
| Q4 25 | 2.58× | — | ||
| Q3 25 | 6.41× | — | ||
| Q2 25 | 5.17× | — | ||
| Q1 25 | 3.57× | — | ||
| Q4 24 | 2.64× | — | ||
| Q3 24 | 3.40× | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-1.4M |
| Free Cash FlowOCF − Capex | $-2.8M | $-2.4M |
| FCF MarginFCF / Revenue | -14.6% | -7.1% |
| Capex IntensityCapex / Revenue | 1.4% | 2.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.5M | $-1.4M | ||
| Q3 25 | $-3.5M | — | ||
| Q2 25 | $-1.2M | $7.9M | ||
| Q1 25 | $-702.0K | $3.0M | ||
| Q4 24 | $-2.9M | $7.2M | ||
| Q3 24 | $-4.4M | $22.2M | ||
| Q2 24 | $-4.3M | $4.0M | ||
| Q1 24 | $-6.3M | $-5.7M |
| Q4 25 | $-2.8M | $-2.4M | ||
| Q3 25 | $-4.1M | — | ||
| Q2 25 | $-1.5M | $7.5M | ||
| Q1 25 | $-757.0K | $654.0K | ||
| Q4 24 | $-3.2M | $5.1M | ||
| Q3 24 | $-4.6M | $18.2M | ||
| Q2 24 | $-4.6M | $2.8M | ||
| Q1 24 | $-6.4M | $-7.7M |
| Q4 25 | -14.6% | -7.1% | ||
| Q3 25 | -31.5% | — | ||
| Q2 25 | -13.2% | 15.1% | ||
| Q1 25 | -8.0% | 1.4% | ||
| Q4 24 | -22.4% | 17.1% | ||
| Q3 24 | -40.0% | 323.0% | ||
| Q2 24 | -38.0% | 5.8% | ||
| Q1 24 | -62.2% | -20.8% |
| Q4 25 | 1.4% | 2.9% | ||
| Q3 25 | 4.0% | 2.0% | ||
| Q2 25 | 2.3% | 0.8% | ||
| Q1 25 | 0.6% | 5.1% | ||
| Q4 24 | 1.7% | 7.0% | ||
| Q3 24 | 1.3% | 71.4% | ||
| Q2 24 | 2.4% | 2.5% | ||
| Q1 24 | 0.3% | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.93× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
